Clinical Trial Update: Efficacy of Diltiazem to Improve Coronary Microvascular Dysfunction: a Randomized Clinical Trial [Phase 3]

View source ↗

Summary

A Phase 3 randomized trial assessing whether diltiazem improves microvascular dysfunction in patients with microvascular angina and coronary vasospasm.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Vasospasm
• Microvascular Angina
• Microvascular Ischemia of Myocardium

Drugs mentioned

• Diltiazem (diltiazem)

Snippet

Sponsor: Radboud University Medical Center | Conditions: Microvascular Angina, Coronary Vasospasm | Phase 3 | Status: ACTIVE_NOT_RECRUITING